Browse Category
Third-Party Risk Management
28 Articles
Daily News
US Sanctions Nigeria-Based Firm Over Alleged Iran Missile Procurement
PSC Dismisses Three Senior Police Officers, Demotes 16 in Disciplinary Sweep
NCC, Customs Move to Stop Counterfeit Phones from Entering Nigeria
Lagos Threatens Sanctions Against ISPs Over Poorly Maintained Cables
13
Aug
Texas Genetics Lab and Former Executives Pay $36.4m to Settle Kickback Allegations
Access DX, a Houston-based genetic testing laboratory, has agreed to a $36.4m...
11
Aug
OCC Rejects Bunq’s U.S. Bank Charter Over Capital, Management and Compliance Concerns
The U.S. Office of the Comptroller of the Currency (OCC) has rejected Dutch...
11
Aug
UBS Hit With Record $125m Penalty for ‘Willful’ Bank Secrecy Act Violations
UBS Financial Services has been hit with a record $125 million civil penalty by...
07
Aug
EU Crypto Platform Ban Signals New Compliance Imperatives Ahead of 25 August Deadline
Compliance teams across the financial services and digital asset sectors are...
07
Aug
OFAC Targets Iranian Currency Exchange Network and Overseas Front Companies in Latest Counter-Terrorism Sanctions
The US Department of the Treasury’s Office of Foreign Assets Control...
07
Aug
Banking Regulators Tighten BaaS Oversight as Fintech Partner Risk Comes Under Greater Scrutiny
Banking-as-a-Service (BaaS) providers and fintech firms are facing heightened...
07
Aug
Expanded Sanctions Lists Increase Secondary Sanctions Risks Across Global Supply Chains
Compliance professionals are being urged to conduct immediate reviews of global...
07
Aug
EU Tightens Energy Sanctions with New Refinery Transaction Bans and Expanded Oil Trade Restrictions
The European Union has strengthened its energy sanctions regime by introducing...
07
Aug
AI-Powered Third-Party Risk Management Gains Momentum with Dun & Bradstreet’s Partn-R Upgrade
As regulatory scrutiny of third-party relationships continues to intensify...
05
Aug
China’s 2026 Pharma Compliance Crackdown: Regulators Target Hidden Bribes, Fake Consulting Fees and Clinical Data Fraud
China’s pharmaceutical industry is facing a new wave of compliance pressure as...
